Treatment and outcome in 31 cases of recurrent medulloblastoma arising in childhood are described. As initial treatment, all patients underwent some degree of tumor resection, and 28 patients received radiation therapy postoperatively. The younger children tended to have recurrence earlier after the ini tial treatment and to die sooner after recurrence than the older children. Early recurrences (within the first 2 postoperative years) often took the form of spinal subarachnoid dissemination, whereas late recurrences (after more than 2 years postoperatively) most often involved intracranial regrowth. Pa tients who underwent extensive tumor resection and received higher doses of radiation to the entire neuraxis generally had longer remission than those who had less extensive tumor removal and lower doses of radiation. Two of four patients who received intrathecal chemotherapy with methotrexate, cytosine arabinoside, and hydrocortisone as part of the initial treatment had remission lasting more than 3 years. The usual treatment for recurrent medulloblastoma was reirradiation, which generally im proved survival time. Tumor removal plus intrathecal chemotherapy in selected cases of recurrence also provided abatement of symptoms. Early recurrence was usually difficult to control, whereas treat ment for late recurrence was generally palliative but not curative. Average survival was 4.3 months after early recurrence, and 21.9 months following late recurrence. Two of the nine patients subjected to autopsy had no local recurrence but had extensive spinal subarachnoid dissemination. At the time of initial extensive tumor resection, irradiation or intrathecal chemotherapy, or both, should be added to prevent regrowth of the tumor and subarachnoid dissemination.
Introduction
The results of surgery alone for cerebellar medulloblastoma have been discouraging.6,291 The development of such therapy as whole neuraxis ir radiation has significantly improved the 5-year sur vival to 33% to 73%, as reported in some series. 2,6,13,15,17) However, 40% to 60% of patients have recurrence within 5 years after initial treat ment. 4,1o,12,18,25 The poor results of treatment are thought to be due to the tumor's infiltrative growth into the brain stem and its great tendency to disseminate to the cerebrospinal fluid (CSF). No therapeutic regimen available at present can cure recurrent growth, and thus the management of medulloblastoma remains a perplexing problem.
In by physical and neurological examinations in con junction with computed tomography, vertebral angiography, myelography, C SF cytology, or biop sy. The patients were followed until death; follow-up of long-term survivors ranged from 4.2 to 7.9 years after the initial diagnosis. Autopsies were performed on nine patients who had been retreated for recur rence.
Results
The patients ranged in age from 6 months to 15 years, with an average of 7.6 years and a median of 8 years, at the time of diagnosis. Twenty-two were boys and nine were girls. The primary tumors were all located in the posterior cranial fossa. Of the 31 pa tients, 27 died before December, 1984.
I. Clinical features of recurrent disease
The length of remission after initial treatment (postoperative period without signs of recurrence) ranged from 1.5 to 61 months, averaging 18.8 months (median, 15 months) (Fig. 1) .
Early and late recurrence: Early recurrence was defined as that which developed within 2 years follow ing surgery, and late recurrence as that which developed more than 2 years postoperatively ( Table  1) . The average age was younger for early and older for late recurrences. All 19 patients with early recur rence died within 3 years after the initial diagnosis and within 13 months (average, 4.3 months) after recurrence.
The 12 patients with late recurrence survived an average of 21.9 months (range, 2 to 53 months) after recurrence; 10 survived more than 3 years after the initial diagnosis.
Site of recurrence: The principal sites of the initial recurrence are shown in Fig. 2 . Of the 19 children with early recurrence, seven had local intracranial regrowth, nine had spinal subarachnoid dissemina tion, and three had both. Late recurrence was ob served in the posterior cranial fossa in nine patients, in both the posterior cranial fossa and the spinal subarachnoid space in two, and in the spinal subarachnoid space in one. Eighty percent of subarachnoid dissemination occurred within 2 years after the initial operation.
The relationship between the site of recurrence and the survival period after recurrence is shown in Fig. 3 . Patients with intracranial recurrence generally lived longer after the recurrence (average survival, 17.5 months) than those with spinal metastases (average survival, 4.5 months).
II.
Treatment Initial treatment and recurrence:
The extent of initial surgery was clearly related to the duration of remission; patients who underwent extensive tumor resection tended to have longer remission (Table 1) . Radiation therapy, if included in the treatment plan, was given after surgery. Of the 31 patients we studied, eight were treated between 1959 and 1968 and 23 were treated after 1969. Between 1959 and 1968, only the posterior cranial fossa was irradiated. Since 1969, whole neuraxis irradiation has usually been given. Twenty patients received whole neuraxis irradiation, but three received radiation only to the whole brain and posterior cranial fossa because of their poor conditions. The radiation plan was to give 3,000 rads to the whole brain, an additional 2,000 rads to the posterior cranial fossa, and 3,000 rads to the whole spine, over 10 to 11 weeks. However, about three fourths of the patients could not tolerate the full dose of spinal irradiation because of leuko penia or thrombocytopenia. *Of the total of 54 children treated , 23 were excluded from our consideration, 18 because of inadequate follow-up or early death (within 1 month after initial surgery) and five because they had no recurrence. These five patients have survived without recurrence for over 10 years postoperatively, and all have surpassed the risk period of Collins et al.') Of the 20 patients who received radiation to the whole neuraxis, seven developed spinal sub arachnoid dissemination, 10 had local regrowth, and three had both spinal subarachnoid dissemination and intracranial regrowth at the time that recurrence was discovered. Of the 11 patients who had no radia tion to the spine, six developed spinal subarachnoid dissemination.
Of the 19 patients who had early recurrence, 16 had received radiation therapy. All the patients who had late recurrence had received radiation therapy. The average doses of radiation were smaller in the early recurrence group than in the late recurrence group, though the difference was not significant (Table 1) . Intrathecal chemotherapy with methotrex ate, cytosine arabinoside, and hydrocortisone was ad ministered in four recent cases. The total doses varied among the patients, but a usual dosage was 60 mg/m2 of methotrexate, 120 mg/m2 of cytosine arabinoside, and 80 mg/m2 of hydrocortisone, given in four lumbar punctures within 2 weeks following surgery. Three of the four patients who received intra thecal chemotherapy and whole spine irradiation did not develop spinal subarachnoid dissemination, whereas nine of the 16 who received irradiation to the spine without intrathecal chemotherapy develop ed spinal subarachnoid dissemination as the initial recurrence.
Retreatment: Twenty of the 31 children were retreated for recurrence by irradiation and/or intra thecal and systemic chemotherapy, and some of them were also reoperated (Table 2) . Eleven received no retreatment. Patients who were retreated lived for an average of 15.1 months thereafter, and five survived longer than 2 years after the retreatment. Patients who were not retreated lived for an average of 4.2 months and all died within 9 months after recur rence. Among the patients with early recurrence, retreatment did not affect the length of survival (Fig.  3 ). Eleven patients with late recurrence were retreated and survived for an average of 23.4 months. One patient who was not retreated died 6 months after late recurrence.
Patients with intracranial local recurrence who were retreated survived for an average of 22.5 months after recurrence; in the non-retreated group, the average survival period was 5.0 months. Re treated patients with spinal subarachnoid dissemina tion survived for an average of 4.8 months after re currence, and non-retreated patients for 4.1 months.
The tumor was re-excised in four patients with intracranial local regrowth. The second operation benefited all four, and three survived for an average of 14.7 months after surgery.
A second course of radiation therapy was ad ministered to 14 patients who had recurrence. For intracranial regrowths, 1,800 to 5,900 rads were administered to the whole brain or to the posterior cranial fossa. Spinal metastases were irradiated with 1,000 to 3,000 rads. The average post-recurrence sur vival of the 14 reirradiated patients was 17 months (median, 10 months), whereas that of the non reirradiated patients was 6.3 months (median, 3 months). Reirradiation was generally beneficial, and radiological evidence of two patients' metastatic tumor disappeared.
One patient was irradiated for metastasis in the right humerus.
Intrathecal chemotherapy was administered to five patients with recurrence, three of whom also re ceived additional irradiation.
The chemotherapy was effective in two cases but was ineffective in three cases of advanced subarachnoid dissemination. The post-recurrence survival of these patients ranged from 3 to 52 months, averaging 17.5 months (median, 11 months).
III. Autopsy findings
The locations of the tumors, as determined by autopsy, were in the primary site, the subarachnoid space, and/or the ventricular wall. 
Discussion
In comparing children who had early recurrence of medulloblastoma (within 2 years of initial surgery) with those who had late recurrence (more than 2 years postoperatively), we found differences in the age at initial diagnosis, the site of recurrence, the initial operative procedure, the radiation dose and the length of survival after recurrence.
Silverman and Simpson29' concluded that there is no correlation between survival and age. Many authors, 2,12,24,25) however, have reported lower sur vival rates in younger than in older individuals. In our series, the younger children had recurrences sooner after initial treatment than did the older :hildren. Also, the younger patients died sooner than he older ones after recurrence was detected. 
